Early-onset pancreatic cancer patients benefit more from neoadjuvant chemotherapy and surgery Post author:admin Post published:August 7, 2025 Post category:uncategorized The incidence of early-onset pancreatic cancer (EOPC) is rising, yet optimal treatment strategies remain unclear. You Might Also Like Neutral polymer enables safer DNA delivery into cells February 22, 2026 Lithocholic acid enhances health and lifespan, mimicking calorie restriction January 1, 2025 Rwanda confronts a surprising surge in malaria September 15, 2025